PHOSPHOLIPASE C INHIBITORS FOR USE IN TREATING INFLAMMATORY DISORDERS

摘要

This invention is directed to heterocyclyl-substituted anilino phospholipase C inhibitor compounds and enantiomers, diastereomers and pharmaceutically acceptable salts thereof useful in treating or ameliorating an inflammatory disorders and/or restenosis. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions affected by phospholipase modulation.